🔗 Permalink

Inventor profile of:

Gerd Wallukat

City:

Berlin

Country:

Germany

Published Applications:

Last publication date:

2024-06-13

Top Assignees for applications by Gerd Wallukat

The entities that hold a legal rights for patent applications filed by inventor Wallukat Gerd:

MAX-DELBRUECK-CENTRUM FUER MOLEKULARE MEDIZIN 7 Berlin, Germany
Fresenius Medical Care Deutschland GmbH 3 Bad Homburg, Germany
MDC Max-Delbruck-Centrum fur Molekulare Medizin Berlin-Buch 2 Berlin-Buch, Germany
BOARD OF REGENTS OF UNIVERSITY OF TEXAS SYSTEM 2 Austin, TX United States
Max-Delbrueck-Centrum fuer Molekulare Medizin (MDC) 1 Berlin, Germany
Board of Regents, The University of Texas System 1 Austin, TX United States
MAX-DELBRUCK-CENTRUM FUR MOLEKULAR MEDIZIN 1 Berlin, Germany
Max-Delbrück-Centrum für Molekulare Medizin 1 , Germany
FRIEDRICH-ALEXANDER-UNIVERSITAET ERLANGEN-NUERNBER G 1 Erlangen, Germany
APTA Therapeutics GmbH 1 Berlin, Germany
CHARITÉ-UNIVERSITAETSMEDIZIN BERLIN 1 Berlin, Germany
CHARITE—UNIVERSTATSMEDIZIN BERLIN 1 Berlin, Germany
Fresenius Medical Care Affina GmbH 1 Berlin, Germany
CHARITE-UNIVERSITAETSMEDIZIN BERLIN 1 Berlin, Germany
Max-Delbrueck-Centrum fuer Molkulare Medizin 1 , Germany
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN 1 BERLIN, Germany
Charite-Universitatsmedizin Berlin 1 Berlin, Germany

Recent patent applications by Wallukat Gerd

Gerd Wallukat from Berlin, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-06-13

US20240191241A1

Chemistry; metallurgy

APTAMERS FOR USE IN THE TREATMENT OF CORONAVIRIDAE INFECTIONS

#2 | 2023-05-04

US20230140490A1

Chemistry; metallurgy

APTAMERS FOR USE IN THE TREATMENT OF CORONAVIRIDAE INFECTIONS

#3 | 2019-10-17

US20190315701A1

Chemistry; metallurgy

Eicosanoid derivatives

#4 | 2018-05-10

US20180127757A1

Chemistry; metallurgy

Use of aptamers in therapy and/or diagnosis of autoimmune diseases

#5 | 2017-01-12

US20170008918A1

Chemistry; metallurgy

CYP-eicosanoid derivatives

#6 | 2016-11-10

US20160326128A1

Chemistry; metallurgy

Eicosanoid derivatives

#7 | 2016-06-09

US20160160218A1

Chemistry; metallurgy

Use of aptamers in therapy and/or diagnosis of autoimmune diseases

#8 | 2014-06-05

US20140155466A1

Chemistry; metallurgy

Use of aptamers in therapy and/or diagnosis of autoimmune diseases

#9 | 2013-11-14

US20130302292A1

Chemistry; metallurgy

Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor

#10 | 2012-05-17

US20120122972A1

Chemistry; metallurgy

Eicosanoid derivatives

#11 | 2011-05-05

US20110104226A1

Chemistry; metallurgy

Peptides having binding affinity to an antibody which recognizes an epitope on an α1 loop 2 or β2 loop 1 of an adrenoreceptor

#12 | 2010-06-29

US9868967

Peptides of the ATreceptor and their uses

#13 | 2009-09-03

US20090220469A1

Chemistry; metallurgy

PEPTIDES AGAINST AUTOANTIBODIES ASSOCIATED WITH GLAUCOMA AND USE OF THESE PEPTIDES

#14 | 2009-01-22

US20090023662A1

Human necessities

Identification of Agonistic Autoantibodies Associated with Humoral Kidney Rejection

#15 | 2007-02-01

US20070026396A1

Performing operations; transporting

Peptides against autoantibodies causing intolerance to cold and use thereof

#16 | 2006-11-23

US20060263835A1

Physics

Identification of agonistic autoantibodies

#17 | 2006-02-07

US10088681

Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (DCM)

InventorID:

528227 ⎘